RE:RE:RE:RE:RE:RE:RE:RE:A move all Oncy shareholders need to make, to screw the shorAssuming a buyout of $5 billion. Which is on record by all analysts as one years income, very possible. $5 billion buyout would be $60/ ps. The upper end? Depends on how things progress within the next few trial updates. Lower end..? They have said many times $1 billion is a minimum staring point. That was long before the recent biotech market place activities. Again acquisition of much less than the Two phase 3 FDA fast track approved. With Roche- tecentriq cotherapy. That being muc( less than that & paying well over $10 billion. I agree 100% Onc is not Apple. However I remember quite clearly you could buy apple shares for $1. Todays share price of any company, has no bearing what so ever of future share price. I get a kick out of the fools who bought into Trumps IPO He needed money to fund his criminal trials & he reached out to his supporters. Im not political. Being Canadian cant vote If I could what a disaste4 you guys have. Trump is on trial on multiple fronts , being supported by anyone he can con. Biden regardless of policies is too old for the job. Back to Onc & I apologize for getting of topic. Any company @ any time can have a paradigm shift & see both rapid decline or rapid acceleration of share price.. Getting Pelareorep into phase 3 with a partner , would be a paradigm shift. Be careful with any company SP. Best opportunities are the ones beaten down with huge upside. Worst opportunities, high flying dream companies. I could fill pages with examples, both sides of the argument. One could debate either way. What matters as an onc investor, which I am. Can Onc get Pela approved for Market? They need further studies & as of two weeks ago, approached FDA with s proposal. The pancreatic trials are increasing enrolment. Know it is written clearly that would only happen with positive data to that point.. So for what I can see, oncolyitics biotech has ample room to initiate the needed paradigm shift. Imho the upside opportunity is far greater than the downside.